Cabergoline generally has a good safety profile, but side effects can occur. The most common are nausea, vomiting, and dizziness. These typically resolve on their own or with dosage adjustments. Less frequent but more serious side effects include orthostatic hypotension (a sudden drop in blood pressure upon standing), fibrosis (scarring of tissues), and valvular heart disease. Fibrosis can affect the lungs, heart valves, and retroperitoneal space (behind the abdominal cavity). Regular monitoring is therefore recommended.
Cardiac monitoring, including echocardiograms, might be advised for long-term users, especially those with pre-existing heart conditions or risk factors. This helps detect potential valvular heart disease early. Report any unusual shortness of breath, chest pain, or palpitations to your doctor immediately. Furthermore, consider reporting any sudden fainting or lightheadedness.
Psychiatric side effects, such as depression, anxiety, and hallucinations, are less common but need prompt medical attention. Inform your doctor about any changes in mood or mental state. Also, women should carefully consider pregnancy plans, as Cabergoline can affect fertility and is not recommended during pregnancy or breastfeeding.
Always discuss any concerns or side effects with your prescribing physician. They can help manage potential risks and adjust your treatment plan accordingly. Remember, individual responses to medications vary. Open communication with your doctor is vital for safe and effective medication management.
